Management of Pediatric OSA Post T&A 2017
2017 AAO-HNSF Annual Meeting & OTO Experience
The first line treatment for obstructive sleep apnea (OSA) in children is adenotonsillectomy (T&A). Persistent OSA occurs in 30% of otherwise healthy children after T&A. In children who are obese, or have craniofacial, genetic or neuromuscular disorders, persistent OSA after T&A is as high as 70%. Thus, otolaryngologists are increasingly managing this challenging patient population. Despite this, there are no guidelines regarding the optimal management of these children. A number of options will be discussed including the role of observation; drug induced sleep endoscopy (DISE); cine MRI; allergy evaluation; CPAP; and turbinate, palatal and tongue base surgeries.
Description
The first line treatment for obstructive sleep apnea (OSA) in children is adenotonsillectomy (T&A). Persistent OSA occurs in 30% of otherwise healthy children after T&A. In children who are obese, or have craniofacial, genetic or neuromuscular disorders, persistent OSA after T&A is as high as 70%. Thus, otolaryngologists are increasingly managing this challenging patient population. Despite this, there are no guidelines regarding the optimal management of these children. A number of options will be discussed including the role of observation; drug induced sleep endoscopy (DISE); cine MRI; allergy evaluation; CPAP; and turbinate, palatal and tongue base surgeries.Learning Objectives: 1. Examine the challenges (and solutions) for managing children with persistent OSA after T&A.2. Assess the modalities for evaluation and treatment of children with persistent OSA.3. Propose an algorithm for the management of children with persistent OSA.Faculty: Ron B. Mitchell, MD (Nothing to disclose), Stacey L. Ishman, MD, MPH (Medtronic ( Consulting fees or honoraria (independent contractor/speakers bureau/advisory committees/review panels)): Consultant/Advisory Board)).
